NLF3: A Potential Drug Target for Cancer and Angiogenesis (G126567)

Target Name: C2CD4C

NCBI ID: G126567

C2CD4C

NLF3: A Potential Drug Target for Cancer and Angiogenesis

C2CD4C, also known as NLF3, is a protein that is expressed in a variety of tissues throughout the body. It is a member of the NLF (nucleases like Flexible and Defiguring) family, which are involved in the regulation of cellular processes such as cell adhesion, migration, and invasion. NLF3 has been shown to play a role in the regulation of cancer cell growth and metastasis.

One of the key functions of NLF3 is its ability to interact with other proteins, including the transcription factor NF-kappa-B. NF-kappa-B is a protein that plays a role in regulating gene expression and cell behavior, and is often involved in the regulation of inflammation and cancer. The interaction between NLF3 and NF-kappa-B has been shown to be involved in the regulation of cellular processes such as cell growth, survival, and angiogenesis.

Another function of NLF3 is its ability to interact with the protein PDGFR-尾. PDGFR-尾 is a receptor that is involved in the regulation of cell growth and angiogenesis. The interaction between NLF3 and PDGFR-尾 has been shown to be involved in the regulation of cellular processes such as cell adhesion, migration, and invasion.

In addition to its role in interacting with NF-kappa-B and PDGFR-尾, NLF3 has also been shown to play a role in the regulation of cellular processes such as cell death, cell cycle progression, and the regulation of cellular signaling pathways.

Given its role in the regulation of cellular processes, NLF3 has been considered as a potential drug target for a variety of diseases. For example, studies have shown that NLF3 is often overexpressed in cancer cells, and that inhibiting its activity may be an effective way to treat cancer. Additionally, the interaction between NLF3 and PDGFR-尾 has been shown to be involved in the regulation of cell growth and angiogenesis, which may make NLF3 an attractive target for treatments that are aimed at regulating these processes.

In conclusion, C2CD4C (NLF3) is a protein that has been shown to play a role in the regulation of a variety of cellular processes. Its interaction with NF-kappa-B and PDGFR-尾 has also been shown to be involved in the regulation of cellular processes such as cell growth, survival, and angiogenesis. As a result, NLF3 has been considered as a potential drug target for the treatment of a variety of diseases. Further research is needed to fully understand the role of NLF3 in cellular processes and its potential as a drug target.

Protein Name: C2 Calcium Dependent Domain Containing 4C

The "C2CD4C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C2CD4C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets